142 related articles for article (PubMed ID: 24934782)
1. How well does supplemental screening magnetic resonance imaging work in high-risk women?
Berg WA
J Clin Oncol; 2014 Jul; 32(21):2193-6. PubMed ID: 24934782
[No Abstract] [Full Text] [Related]
2. Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the ontario high risk breast screening program.
Chiarelli AM; Prummel MV; Muradali D; Majpruz V; Horgan M; Carroll JC; Eisen A; Meschino WS; Shumak RS; Warner E; Rabeneck L
J Clin Oncol; 2014 Jul; 32(21):2224-30. PubMed ID: 24934793
[TBL] [Abstract][Full Text] [Related]
3. MRI breast screening in high-risk women: cancer detection and survival analysis.
Evans DG; Kesavan N; Lim Y; Gadde S; Hurley E; Massat NJ; Maxwell AJ; Ingham S; Eeles R; Leach MO; ; Howell A; Duffy SW
Breast Cancer Res Treat; 2014 Jun; 145(3):663-72. PubMed ID: 24687378
[TBL] [Abstract][Full Text] [Related]
4. Breast MRI: opportunities and challenges.
Day D
Minn Med; 2009 Dec; 92(12):45-8. PubMed ID: 20092173
[TBL] [Abstract][Full Text] [Related]
5. Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma.
Hartman AR; Daniel BL; Kurian AW; Mills MA; Nowels KW; Dirbas FM; Kingham KE; Chun NM; Herfkens RJ; Ford JM; Plevritis SK
Cancer; 2004 Feb; 100(3):479-89. PubMed ID: 14745863
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging for preoperative evaluation of breast cancer: a comparative study with mammography and ultrasonography.
Hata T; Takahashi H; Watanabe K; Takahashi M; Taguchi K; Itoh T; Todo S
J Am Coll Surg; 2004 Feb; 198(2):190-7. PubMed ID: 14759774
[TBL] [Abstract][Full Text] [Related]
7. Mammographic, US, and MR imaging phenotypes of familial breast cancer.
Schrading S; Kuhl CK
Radiology; 2008 Jan; 246(1):58-70. PubMed ID: 18096529
[TBL] [Abstract][Full Text] [Related]
8. Overdiagnosis in mammography screening: a 45 year journey from shadowy idea to acknowledged reality.
Barratt A
BMJ; 2015 Mar; 350():h867. PubMed ID: 25736426
[No Abstract] [Full Text] [Related]
9. Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition.
Kriege M; Brekelmans CT; Boetes C; Muller SH; Zonderland HM; Obdeijn IM; Manoliu RA; Kok T; Rutgers EJ; de Koning HJ; Klijn JG;
Cancer; 2006 Jun; 106(11):2318-26. PubMed ID: 16615112
[TBL] [Abstract][Full Text] [Related]
10. How to prevent invasive breast cancer: detect and excise duct carcinoma in situ.
Cady B
J Surg Oncol; 1998 Oct; 69(2):60-2. PubMed ID: 9808505
[No Abstract] [Full Text] [Related]
11. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance mammography in small vs. advanced breast lesions - systematic comparison reveals significant impact of lesion size on diagnostic accuracy in 936 histologically verified breast lesions.
Dietzel M; Baltzer PA; Vag T; Gröschel T; Richter C; Burmeister H; Kaiser WA
Rofo; 2011 Feb; 183(2):126-35. PubMed ID: 20830650
[TBL] [Abstract][Full Text] [Related]
13. MR mammography is useful in the preoperative locoregional staging of breast carcinomas with extensive intraductal component.
Van Goethem M; Schelfout K; Kersschot E; Colpaert C; Verslegers I; Biltjes I; Tjalma WA; De Schepper A; Weyler J; Parizel PM
Eur J Radiol; 2007 May; 62(2):273-82. PubMed ID: 17223002
[TBL] [Abstract][Full Text] [Related]
14. Computer-aided detection system applied to full-field digital mammograms.
Bolivar AV; Gomez SS; Merino P; Alonso-Bartolomé P; Garcia EO; Cacho PM; Hoffmeister JW
Acta Radiol; 2010 Dec; 51(10):1086-92. PubMed ID: 20883182
[TBL] [Abstract][Full Text] [Related]
15. Balancing sensitivity and specificity: sixteen year's of experience from the mammography screening programme in Copenhagen, Denmark.
Utzon-Frank N; Vejborg I; von Euler-Chelpin M; Lynge E
Cancer Epidemiol; 2011 Oct; 35(5):393-8. PubMed ID: 21239242
[TBL] [Abstract][Full Text] [Related]
16. Patient age and preoperative breast MRI in women with breast cancer: biopsy and surgical implications.
Adkisson CD; Vallow LA; Kowalchik K; McNeil R; Hines S; Deperi E; Moreno A; Roy V; Perez EA; McLaughlin SA
Ann Surg Oncol; 2011 Jun; 18(6):1678-83. PubMed ID: 21207171
[TBL] [Abstract][Full Text] [Related]
17. Overcalling low-risk findings: grouped amorphous calcifications found at screening mammography associated with minimal cancer risk.
Iwase M; Tsunoda H; Nakayama K; Morishita E; Hayashi N; Suzuki K; Yamauchi H
Breast Cancer; 2017 Jul; 24(4):579-584. PubMed ID: 27873170
[TBL] [Abstract][Full Text] [Related]
18. MRI of the breast as part of the assessment in population-based mammography screening.
Bick U; Engelken F; Diederichs G; Dzyuballa R; Ortmann M; Fallenberg EM
Rofo; 2013 Sep; 185(9):849-56. PubMed ID: 23740312
[TBL] [Abstract][Full Text] [Related]
19. Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ.
Solin LJ; Orel SG; Hwang WT; Harris EE; Schnall MD
J Clin Oncol; 2008 Jan; 26(3):386-91. PubMed ID: 18202414
[TBL] [Abstract][Full Text] [Related]
20. Survival of patients with BRCA1-associated breast cancer diagnosed in an MRI-based surveillance program.
Møller P; Stormorken A; Jonsrud C; Holmen MM; Hagen AI; Clark N; Vabø A; Sun P; Narod SA; Mæhle L
Breast Cancer Res Treat; 2013 May; 139(1):155-61. PubMed ID: 23615785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
